Transepithelial leak in Barrett's esophagus
- PMID: 17103306
- DOI: 10.1007/s10620-006-9478-5
Transepithelial leak in Barrett's esophagus
Abstract
Using orally administered sucrose as a probe of gastrointestinal permeability, this study focused on determining whether Barrett's metaplasia exhibits a paracellular transepithelial leak to small nonelectrolytes. Subjects in five separate classes (nonendoscoped, asymptomatic controls; endoscoped, asymptomatic controls; gastroesophageal reflux disease without mucosal complications; grossly visible esophagitis; and Barrett's esophagus) consumed a sucrose solution at bedtime and collected all overnight urine. Urine volume was measured and sucrose concentration was determined by high-performance liquid chromatography. Patients with Barrett's were observed to exhibit a transepithelial leak to sucrose whose mean value was threefold greater than that seen in healthy control subjects or patients with reflux but without any mucosal defect. A parallel study of claudin tight junction proteins in endoscopy biopsy samples showed that whereas Barrett's metaplasia contains dramatically more claudin-2 and claudin-3 than is found in normal esophageal mucosa, it is markedly lower in claudins 1 and 5, indicating very different tight junction barriers.
Similar articles
-
Transepithelial leak in Barrett's esophagus patients: the role of proton pump inhibitors.World J Gastroenterol. 2012 Jun 14;18(22):2793-7. doi: 10.3748/wjg.v18.i22.2793. World J Gastroenterol. 2012. PMID: 22719187 Free PMC article.
-
Ion transport and barrier function in a telomerase-immortalized human nondysplastic, Barrett's cell line (BAR-T).Dis Esophagus. 2009;22(5):386-95. doi: 10.1111/j.1442-2050.2008.00907.x. Dis Esophagus. 2009. PMID: 19673046
-
Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.Am J Gastroenterol. 2005 Jun;100(6):1257-64. doi: 10.1111/j.1572-0241.2005.41338.x. Am J Gastroenterol. 2005. PMID: 15929754
-
Reflux esophagitis and its role in the pathogenesis of Barrett's metaplasia.J Gastroenterol. 2017 Jul;52(7):767-776. doi: 10.1007/s00535-017-1342-1. Epub 2017 Apr 27. J Gastroenterol. 2017. PMID: 28451845 Free PMC article. Review.
-
Cellular Origins of Barrett's Esophagus: the Search Continues.Curr Gastroenterol Rep. 2018 Sep 26;20(11):51. doi: 10.1007/s11894-018-0657-2. Curr Gastroenterol Rep. 2018. PMID: 30259225 Review.
Cited by
-
Increased Toll-like receptor 5 expression indicates esophageal columnar dysplasia.Virchows Arch. 2014 Jan;464(1):11-8. doi: 10.1007/s00428-013-1505-2. Epub 2013 Nov 13. Virchows Arch. 2014. PMID: 24221343
-
Gastrointestinal mucosal barrier function and diseases.J Gastroenterol. 2016 Aug;51(8):768-78. doi: 10.1007/s00535-016-1207-z. Epub 2016 Apr 5. J Gastroenterol. 2016. PMID: 27048502 Review.
-
The epithelial barrier theory and its associated diseases.Allergy. 2024 Dec;79(12):3192-3237. doi: 10.1111/all.16318. Epub 2024 Oct 7. Allergy. 2024. PMID: 39370939 Free PMC article. Review.
-
Transepithelial leak in Barrett's esophagus patients: the role of proton pump inhibitors.World J Gastroenterol. 2012 Jun 14;18(22):2793-7. doi: 10.3748/wjg.v18.i22.2793. World J Gastroenterol. 2012. PMID: 22719187 Free PMC article.
-
Acid suppression therapy and allergic reactions.Allergo J Int. 2015 Dec;24(8):303-311. doi: 10.1007/s40629-015-0085-x. Allergo J Int. 2015. PMID: 28603686 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources